Inhibition of the mechanistic target of rapamycin induces cell survival via MAPK in tuberous sclerosis complex | Orphanet Journal of Rare Diseases | Full Text

Inhibition of the mechanistic target of rapamycin induces cell survival via MAPK in tuberous sclerosis complex | Orphanet Journal of Rare Diseases | Full Text

Inhibition of the mechanistic target of rapamycin induces cell survival via MAPK in tuberous sclerosis complex

Tuberous sclerosis complex (TSC) is a genetic disorder that cause tumors to form in many organs. These lesions may lead to epilepsy, autism, developmental delay, renal, and pulmonary failure. Loss of function ...

Authors:Yiyang Lu, Erik Y. Zhang, Jie Liu and Jane J. Yu

Citation:Orphanet Journal of Rare Diseases 2020 15:209

Content type:Research

 

Published on: 17 August 2020

• ViewFull Text
 
• ViewPDF